Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Enel Chile
ENIC
$6.14B
| $1.93M | ﹤0.01% |
590,347
| – | – |
|
|
AKYA
3502
DELISTED
Akoya BioSciences
AKYA
| $1.93M | ﹤0.01% |
1,388,200
-18,862
| -1% | -$41.3K |
|
3503
Mammoth Energy Services
TUSK
$128M
| $1.93M | ﹤0.01% |
944,535
-2,162
| -0.2% | -$5.76K |
|
3504
Outset Medical
OM
$84.7M
| $1.92M | ﹤0.01% |
173,325
-602
| -0.3% | -$7.18K |
|
3505
Commercial Vehicle Group
CVGI
$154M
| $1.92M | ﹤0.01% |
1,666,706
-22,485
| -1% | -$43.5K |
|
3506
Karyopharm Therapeutics
KPTI
$43.5M
| $1.91M | ﹤0.01% |
510,294
-5
| -0% | -$43 |
|
3507
X4 Pharmaceuticals
XFOR
$375M
| $1.9M | ﹤0.01% |
268,917
-4,446
| -2% | -$61.2K |
|
3508
Great Elm Group
GEG
$67.4M
| $1.9M | ﹤0.01% |
1,004,157
| – | – |
|
3509
Babcock & Wilcox
BW
$1.39B
| $1.89M | ﹤0.01% |
2,819,822
-11,320
| -0.4% | -$14K |
|
3510
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $1.89M | ﹤0.01% |
7,741
-66
| -0.8% | -$17.2K |
|
3511
Rafael Holdings
RFL
$101M
| $1.88M | ﹤0.01% |
1,017,388
+305,398
| +43% | +$592K |
|
|
VIGL
3512
DELISTED
Vigil Neuroscience
VIGL
| $1.87M | ﹤0.01% |
1,048,823
+73,350
| +8% | +$165K |
|
3513
Comstock Holding Companies
CHCI
$145M
| $1.87M | ﹤0.01% |
216,381
| – | – |
|
3514
Coda Octopus Group
CODA
$114M
| $1.86M | ﹤0.01% |
297,827
| – | – |
|
3515
Crown Crafts
CRWS
$31.7M
| $1.84M | ﹤0.01% |
504,809
| – | – |
|
|
CLYM
3516
Climb Bio
CLYM
$681M
| $1.83M | ﹤0.01% |
1,502,556
-3,701
| -0.2% | -$6K |
|
|
FARM
3517
DELISTED
Farmer Brothers
FARM
| $1.83M | ﹤0.01% |
824,693
| – | – |
|
3518
Nano X Imaging
NNOX
$68.2M
| $1.82M | ﹤0.01% |
365,033
-39,809
| -10% | -$276K |
|
|
KYNB
3519
Kyntra Bio
KYNB
$27.2M
| $1.82M | ﹤0.01% |
234,365
-714
| -0.3% | -$8.56K |
|
3520
State Street SPDR S&P Dividend ETF
SDY
$21.7B
| $1.81M | ﹤0.01% |
13,360
+59
| +0.4% | +$7.93K |
|
|
BZAI
3521
Blaize Holdings
BZAI
$112M
| $1.8M | ﹤0.01% |
+892,794
| New | +$4.04M |
|
3522
PDS Biotechnology
PDSB
$38.4M
| $1.8M | ﹤0.01% |
1,510,221
+4,409
| +0.3% | +$6.27K |
|
3523
Marchex
MCHX
$76.2M
| $1.79M | ﹤0.01% |
1,095,784
+333
| +0% | +$647 |
|
3524
OPAL Fuels
OPAL
$71.3M
| $1.78M | ﹤0.01% |
969,013
-214
| -0% | -$586 |
|
3525
Comp X International
CIX
$349M
| $1.78M | ﹤0.01% |
85,941
-489
| -0.6% | -$11.7K |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.